The Role of Late Life Depressive Symptoms on the Trajectories of Insomnia Symptoms During Antidepressant Treatment
Overview
Authors
Affiliations
Objective: Sleep disturbances are common in late life depression; however, changes in insomnia symptoms during antidepressant treatment need to be characterized further. The objective of this study was two-fold: 1) to describe longitudinal trajectories of insomnia symptoms in older adults receiving antidepressant treatment and 2) to examine whether baseline depressive symptoms were associated with trajectories of sleep over time.
Methods: Data was obtained from 680 older adults (aged ≥ 60) with major depression who participated in one of two protocolized open-label antidepressant treatment clinical trials (Maintenance Therapies in Late Life Depression [MTLD-3]; Incomplete Response in Late Life Depression: Getting to Remission [IRL-GRey]). Depression (total score minus sleep items) and sleep (sum of sleep items) outcomes were derived from the Hamilton Depression Rating Scale in the MLTD-3 and Montgomery-Asberg Depression Rating Scale in the IRL-GRey.
Results: Both datasets identified 5 possible trajectories of insomnia symptoms with about half of the older adults having clinically significant baseline sleep disturbances and minimal improvement following a course of antidepressant treatment (i.e., sub-optimal sleep trajectory). Furthermore, across both datasets, worse baseline depression severity was associated with sub-optimal sleep trajectories.
Conclusion: In older adults receiving antidepressant treatment, those with clinically significant baseline sleep disturbances and greater depression severity may require adjunctive sleep-focused treatment to ameliorate sleep symptoms.
Mei X, Zhao Z, Qiu Z, Wang J, Yu H, Zheng C Front Aging Neurosci. 2023; 15:1189837.
PMID: 37621985 PMC: 10445039. DOI: 10.3389/fnagi.2023.1189837.
Dual trajectory of sleep and frail in elderly people.
Zheng Y, Zhou B, Gong N, Chen X Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023; 48(4):621-627.
PMID: 37385626 PMC: 10930250. DOI: 10.11817/j.issn.1672-7347.2023.220544.
Borentain S, Williamson D, Turkoz I, Popova V, McCall W, Mathews M Neuropsychiatr Dis Treat. 2021; 17:3459-3470.
PMID: 34880615 PMC: 8646953. DOI: 10.2147/NDT.S339090.
Boland E, Vittengl J, Clark L, Thase M, Jarrett R J Affect Disord. 2019; 262:323-332.
PMID: 31735410 PMC: 6919563. DOI: 10.1016/j.jad.2019.10.033.